ICI in UC: Spain
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Spain

Released: January 08, 2021

Expiration: January 07, 2022

Activity

Progress
1
Course Completed

In this episode, Félix Guerrero Ramos, MD, PhD, FEBU, and Óscar Rodríguez-Faba, MD, discuss in Spanish the latest immuno-oncology developments in the treatment of urothelial cancer. 

Presenters:

Félix Guerrero Ramos, MD, PhD, FEBU 
Teaching Collaborator
Department of Surgery
Medicine School
Universidad Complutense de Madrid
Attending Urologist
Department of Urology
UroOncology Unit
Madrid, Spain 

Óscar Rodríguez-Faba, MD 
Urologist
Uro-Oncology
Fundació Puigvert
Barcelona, Catalonia, Spain